Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 17,305	$ 17,957
Accounts receivable, net	257,913	155,273
Inventories	159,462	110,683
Deferred income taxes	2,168	1,813
Prepaid expenses and other current assets	15,886	5,360
Total current assets	452,734	291,086
Property and equipment, net	14,187	13,150
Capitalized software for internal use, net	35,417	13,236
Goodwill	250,544	23,148
Intangible assets, net	242,882	44,973
Investment in non-consolidated entity	3,500	3,500
Deferred debt issuance costs	5,681	921
Other noncurrent assets	234	72
Total assets	1,005,179	390,086
Current liabilities:
Accounts payable	265,565	202,495
Borrowings on line of credit	70,994
Short-term debt, including current portion of long-term debt	6,000
Accrued expenses:
Contingent consideration	47,681	6,282
Compensation and benefits	5,682	2,257
Other	6,142	4,394
Total current liabilities	402,064	215,428
Long-term debt, less current portion	114,000
Contingent consideration, less current portion	5,179	5,409
Deferred income taxes	11,081	518
Other noncurrent liabilities		4
Total liabilities	$ 532,324	$ 221,359
Commitments and contingencies
Shareholders' equity:
Preferred stock (10,000,000 shares authorized; none issued and outstanding)
Common stock (no par value; 590,000,000 shares authorized; 63,613,867 and 51,457,023 issued and outstanding at June 30, 2015 and December 31, 2014, respectively)	$ 445,280	$ 148,901
Additional paid-in capital	11,857	9,893
Retained earnings	11,603	5,354
Total Diplomat Pharmacy shareholders' equity	468,740	164,148
Noncontrolling interests	4,115	4,579
Total shareholders' equity	472,855	168,727
Total liabilities and shareholders' equity	$ 1,005,179	$ 390,086